Send to

Choose Destination
See comment in PubMed Commons below
J Theor Biol. 2006 Dec 21;243(4):532-41. Epub 2006 Jul 21.

A multiscale mathematical model of avascular tumor growth to investigate the therapeutic benefit of anti-invasive agents.

Author information

  • 1Clinical Pharmacology Department, Institute for Theoretical Medicine, EA 3736, Faculty of Medicine R.T.H Laennec, University of Lyon 1, Paradin St., 69376 Lyon Cedex 08, France.


With the aim of inhibiting cancer growth and reducing the risk of metastasis, pharmaceutical companies in the early 1990s developed anti-metastatic agents called inhibitors of metalloproteinases (MMPi). Despite the promising results obtained in pre-clinical studies, results of Phase III trials have been somewhat disappointing for late stage cancer patients. With the aim of mathematically investigating this therapeutic failure, we developed a mechanistically based model which integrates cell cycle regulation and macroscopic tumor dynamics. By simulating the model, we evaluated the efficacy of MMPi therapy. Simulation results predict the lack of efficacy of MMPi in advanced cancer patients. The theoretical model may aid in evaluating the efficacy of anti-metastatic therapies, thus benefiting the design of prospective clinical trials.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk